Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Preferred Stock Liabilities (2023 - 2024)

Upstream Bio (UPB) has 2 years of Preferred Stock Liabilities data on record, last reported at $380.9 million in Q3 2024.

  • For Q3 2024, Preferred Stock Liabilities rose 64.93% year-over-year to $380.9 million; the TTM value through Sep 2024 reached $380.9 million, up 64.93%, while the annual FY2023 figure was $230.9 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $380.9 million in Q3 2024 per UPB's latest filing, roughly flat from $380.9 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $380.9 million in Q2 2024 and bottomed at $230.9 million in Q3 2023.